shot-button
Subscription Subscription
Home > Mumbai > Mumbai News > Article > Thane Banned tobacco products worth Rs 1 crore seized by FDA

Thane: Banned tobacco products worth Rs 1 crore seized by FDA

Updated on: 23 November,2022 07:50 PM IST  |  Mumbai
mid-day online correspondent |

The police said six persons, including the tempo driver, have been named as accused in the first information report (FIR) registered following the seizure

Thane: Banned tobacco products worth Rs 1 crore seized by FDA

Seized stock by FDA Maharashtra. Pic/FDA

On Wednesday, Maharashtra's Food and Drug Administration (FDA) seized banned tobacco products, including gutkha, worth more than rupees one crore crore from a tempo in Thane, as per the FDA official.


Suresh Deshmukh, Joint Commissioner of FDA, said, "The tempo in which the products were being transported was impounded and its driver detained. We acted on tip-off information given to us about the that banned gutkha and other tobacco products were being smuggled into Thane."


Also Read: Veteran actor Vikram Gokhale hospitalised in Pune following health complications


"The official spotted a tempo passing through the village and stopped it. A search of the vehicle led to the recovery of banned gutkha and tobacco products worth Rs 1.08 crore," he said.

The police said six persons, including the tempo driver, have been named as accused in the first information report (FIR) registered following the seizure.

(with inputs from PTI)

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Is it sweater season in Mumbai already?

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK